PegIntron Interactions
There are 227 drugs known to interact with PegIntron (peginterferon alfa-2b), along with 20 disease interactions. Of the total drug interactions, 41 are major, 182 are moderate, and 4 are minor.
- View all 227 medications that may interact with PegIntron
- View PegIntron disease interactions (20)
Most frequently checked interactions
View interaction reports for PegIntron (peginterferon alfa-2b) and the medicines listed below.
- acyclovir
- adefovir
- amitriptyline
- amoxicillin / clavulanate
- Aptivus (tipranavir)
- Benadryl (diphenhydramine)
- boceprevir
- clarithromycin
- Coumadin (warfarin)
- entecavir
- folic acid
- gabapentin
- ganciclovir
- Haldol Decanoate (haloperidol)
- hydroxyzine
- ibuprofen
- Implanon (etonogestrel)
- Incivek (telaprevir)
- interferon alfa-2a
- isoniazid
- Janumet (metformin / sitagliptin)
- Januvia (sitagliptin)
- Klonopin (clonazepam)
- lamivudine
- ledipasvir / sofosbuvir
- Levemir (insulin detemir)
- Pegasys (peginterferon alfa-2a)
- Ribasphere (ribavirin)
- ribavirin
- Victrelis (boceprevir)
PegIntron disease interactions
There are 20 disease interactions with PegIntron (peginterferon alfa-2b) which include:
- renal dysfunction
- autoimmune diseases
- cardiac disease
- CNS dysfunction
- depression
- thyroid dysfunction
- autoimmune hepatitis
- depression
- severe hepatic disease
- hemoglobinopathies
- renal dysfunction
- colitis
- diabetes mellitus
- myelosuppression
- peripheral neuropathy
- bone marrow suppression
- endocrine disorders
- ophthalmological disorders
- pancreatitis
- pulmonary disorders
Report options
QR code containing a link to this page
More about PegIntron (peginterferon alfa-2b)
- PegIntron consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic interferons
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.